FIBROGEN INC Quarterly Cost of Revenue in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Fibrogen Inc quarterly/annual Cost of Revenue history and growth rate from Q3 2020 to Q3 2024.
  • Fibrogen Inc Cost of Revenue for the quarter ending September 30, 2024 was $5.3M, a 24.8% increase year-over-year.
  • Fibrogen Inc Cost of Revenue for the twelve months ending September 30, 2024 was $41.6M, a 127% increase year-over-year.
  • Fibrogen Inc annual Cost of Revenue for 2023 was $18.8M, a 7.06% decline from 2022.
  • Fibrogen Inc annual Cost of Revenue for 2022 was $20.3M, a 57.6% increase from 2021.
  • Fibrogen Inc annual Cost of Revenue for 2021 was $12.9M, a 45.1% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $41.6M $5.3M +$1.05M +24.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $40.6M $5.18M -$530K -9.29% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $41.1M $25.8M +$22.3M +638% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $18.8M $5.41M +$481K +9.77% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $18.4M $4.24M -$65K -1.51% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $18.4M $5.71M -$1.1M -16.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $19.5M $3.49M -$747K -17.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $20.3M $4.93M +$1.8M +57.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $18.5M $4.31M +$1.04M +31.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $17.4M $6.81M +$3.73M +121% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $13.7M $4.24M +$837K +24.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $12.9M $3.13M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $3.27M +$1.06M +48% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $3.08M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $3.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $2.21M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.